Safety and Efficacy of Tofacitinib for Ulcerative Colitis Safety and Efficacy of Tofacitinib for Ulcerative Colitis
This paper presents final data from OCTAVE Open, an open-label, long-term extension study on the safety and efficacy of the Janus kinase inhibitor tofacitinib for the treatment of ulcerative colitis.Alimentary Pharmacology & Therapeutics
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Study | Transplant Surgery | Transplants | Ulcerative Colitis